Dallas, TX -- (SBWIRE) -- 06/15/2015 -- The report "Anesthetic Effect - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Anesthetic Effect, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anesthetic Effect and special features on late-stage and discontinued projects.

Complete report on Anesthetic Effect with 37 market data tables and 14 figures, spread across 85 pages is available at http://www.rnrmarketresearch.com/anesthetic-effect-pipeline-review-h1-2015-market-report.html

Companies discussed in this Anesthetic Effect – Pipeline Review, H1 2015 report include Biolab Sanus Farmaceutica Ltda., Drawbridge Pharmaceuticals Pty Ltd, Jiangsu Hengrui Medicine Co., Ltd., Juniper Pharmaceuticals, Inc., Laboratoires Thea S.A., Lipicard Technologies Limited, Merck & Co., Inc., NanoMedex Pharmaceuticals, Inc., Paion AG, Phosphagenics Limited, Physica Pharma, Proteus SA, Sphaera Pharma Pvt. Ltd., Taiwan Liposome Company, Ltd., The Medicines Company.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are (lidocaine + phenylephrine hydrochloride + tropicamide), (tetracaine + oxymetazoline hydrochloride), ABP-700, ADV-6209, alphaxalone, bupivacaine hydrochloride, carboetomidate, Gabafol, lidocaine ER, LT-1121, LT-1123, methoxycarbonyl carboetomidate, methoxycarbonyl etomidate, neosaxitoxin, PB-5109, PHY-301, propofol, propofol microemulsion, propofol-DM, remimazolam, remimazolam, Small Molecules to Inhibit NMDA Receptor for Anaesthesia, sugammadex sodium.

Order a purchase copy of this report @
http://www.rnrmarketresearch.com/contacts/purchase?rname=390967
(This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases Cover by this report includes:

-Apr 28, 2015: FDA Declines To Approve Merck's Bridion
-Mar 13, 2015: Merck Provides Regulatory Update on Investigational Medicine Sugammadex Injection
-Feb 10, 2015: Drawbridge Pharmaceuticals granted Notice of Allowance for divisional patent in the United States
-Nov 05, 2014: Paion's Partner Ono Decides Not To File For Regulatory Approval Of REMIMAZOLAM In Japan And Will Return Its REMIMAZOLAM Rights For Japan To Paion
-Oct 14, 2014: Invitation To Conference Call Of Paion About The Project Status Of Remimazolam In Japan
-Oct 10, 2014: Paion Expects Ono'S Remimazolm Decision On Filing In Japan In November 2014
-Oct 01, 2014: Two Scientific Remimazolam Presentations Are Accepted for ASA and ACG Meeting in October 2014
-Sep 15, 2014: Drawbridge Pharmaceuticals to present clinical findings of Phaxan at Anesthesiology 2014
-Jul 21, 2014: Drawbridge Pharmaceuticals extends Phaxan patent portfolio with divisional patents granted for other neuroactive steroids
-Jun 18, 2014: Drawbridge Pharmaceuticals granted new anaesthesia patent for Phaxan in China

Inquire for Disocunt @ http://www.rnrmarketresearch.com/contacts/discount?rname=390967
(This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Anesthetic Effect, H1 2015 10
Number of Products under Development for Anesthetic Effect - Comparative Analysis, H1 2015 11
Number of Products under Development by Companies, H1 2015 13
Number of Products under Investigation by Universities/Institutes, H1 2015 14
Comparative Analysis by Late Stage Development, H1 2015 15
Comparative Analysis by Clinical Stage Development, H1 2015 16
Comparative Analysis by Early Stage Development, H1 2015 17
Comparative Analysis by Unknown Stage Development, H1 2015 18
Products under Development by Companies, H1 2015 19
Products under Development by Companies, H1 2015 (Contd..1) 20
Products under Investigation by Universities/Institutes, H1 2015 21
Anesthetic Effect - Pipeline by Advicenne Pharma, H1 2015 22
Anesthetic Effect - Pipeline by Biolab Sanus Farmaceutica Ltda., H1 2015 23
Anesthetic Effect - Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H1 2015 24
Anesthetic Effect - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H1 2015 25
Anesthetic Effect - Pipeline by Juniper Pharmaceuticals, Inc., H1 2015 26
Anesthetic Effect - Pipeline by Laboratoires Thea S.A., H1 2015 27
Anesthetic Effect - Pipeline by Lipicard Technologies Limited, H1 2015 28
Anesthetic Effect - Pipeline by Merck & Co., Inc., H1 2015 29
Anesthetic Effect - Pipeline by NanoMedex Pharmaceuticals, Inc., H1 2015 30
Anesthetic Effect - Pipeline by Paion AG, H1 2015 31
Anesthetic Effect - Pipeline by Phosphagenics Limited, H1 2015 32
Anesthetic Effect - Pipeline by Physica Pharma, H1 2015 33
Anesthetic Effect - Pipeline by Proteus SA, H1 2015 34
Anesthetic Effect - Pipeline by Sphaera Pharma Pvt. Ltd., H1 2015 35
Anesthetic Effect - Pipeline by Taiwan Liposome Company, Ltd., H1 2015 36
Anesthetic Effect - Pipeline by The Medicines Company, H1 2015 37
Assessment by Monotherapy Products, H1 2015 38
Assessment by Combination Products, H1 2015 39
Number of Products by Stage and Target, H1 2015 41
Number of Products by Stage and Mechanism of Action, H1 2015 43
Number of Products by Stage and Route of Administration, H1 2015 45
Number of Products by Stage and Molecule Type, H1 2015 46
Anesthetic Effect Therapeutics - Recent Pipeline Updates, H1 2015 77
Anesthetic Effect - Dormant Projects, H1 2015 82
Anesthetic Effect - Dormant Projects (Contd..1), H1 2015 83
Anesthetic Effect - Discontinued Products, H1 2015 84

Explore more reports on Anesthesia Drugs at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/anesthesia-drugs

About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.